Ian Dalton

Ian is the Head of the Manufacturing and Market Shaping Unit at the UK’s Foreign, Commonwealth and Development Office (FCDO). He has over a decade of senior engagement in Health & the Life Sciences including at the UK’s Medicines Regulatory Agency (MHRA), the European Commission, the OECD and United Nations. Most recently he led the FCDO’s global pharmaceuticals and diagnostics response to COVID-19, including as Chair of the WHO/ACT-Accelerator Pharmaceuticals and Diagnostics Group bringing together Governments, civil society, global health institutions and industry to examine the challenges to access during the pandemic.

He is also an Advisor to the World Health Organisation on Regional Manufacturing and Board Member of the Access to Medicines Foundation, bringing an in-depth knowledge of institutional and delivery architectures, alongside a well-established understanding of regulatory and policy frameworks.